Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 93 Records) |
| Query Trace: Colorectal Neoplasms and XRCC1[original query] |
|---|
| Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
| Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility. World journal of surgical oncology 2015 13 (1): 244. Huang Yi, Li Xiaohua, He Jing, Chen Lin, Huang Huaxing, Liang Mengdi, Zhu Qiannan, Huang Yaoyu, Wang Li, Pan Chunji, Xia Tianso |
| AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The pharmacogenomics journal 2015 Aug . Kjersem J B, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit K M, Wettergren Y, Kure E |
| Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies. Asian Pacific journal of cancer prevention : APJCP 2015 16 (8): 3285-91. Forat-Yazdi Mohammad, Gholi-Nataj Mohsen, Neamatzadeh Hossein, Nourbakhsh Parisa, Shaker-Ardakani Hosse |
| XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population. Mutagenesis 2015 May 30 (3): 441-9. Dai Qiong, Luo Hua, Li Xing Pu, Huang Juan, Zhou Tie Jun, Yang Zhi-H |
| Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
| Polymorphism of the DNA Repair Gene XRCC1 (Arg194Trp) and its role in Colorectal Cancer in Kashmiri Population: a Case Control Study. Asian Pacific journal of cancer prevention : APJCP 2015 16 (15): 6385-90. Nissar Saniya, Sameer Aga Syed, Rasool Roohi, Chowdri Nissar A, Rashid Fouz |
| XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Feb 36 (2): 461-6. Qin Chang-Jiang, Xu Kai-Wu, Chen Zhi-Hui, Zhai Er-Tao, He Yu-Long, Song Xin-Mi |
| Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis. Pharmacogenomics 2016 Sep . Shahnam Adel, Ridha Zainab, Wiese Michael D, Kichenadasse Ganessan, Sorich Michael |
| Gene polymorphism in DNA repair genes XRCC1 and XRCC6 and association with colorectal cancer in Swedish patients. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016 Sep 124 (9): 736-40. Dimberg Jan, Skarstedt Marita, Slind Olsen Renate, Andersson Roland E, Matussek Andre |
| Lack of Association between an XRCC1 Gene Polymorphism and Colorectal Cancer Survival in Thailand. Asian Pacific journal of cancer prevention : APJCP 2016 17 (4): 2055-60. Siewchaisakul Pallop, Suwanrungruang Krittika, Poomphakwaen Kirati, Wiangnon Surapon, Promthet Supann |
| DNA repair genes polymorphisms and risk of colorectal cancer in Saudi patients. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2016 Sep . Karam Rehab A, Al Jiffry Bilal O, Al Saeed Mohamed, Abd El Rahman Tamer M, Hatem Mohamed, Amer Mona |
| Role of depth of response and MTHFR genotype as predictors of fluorouracil rechallenge therapy for refractory metastatic colorectal cancer. Oncology letters 2017 Aug 14 (2): 2491-2498. Kim Ka-Rham, Yoon Jung-Hwan, Shim Hyun-Jeong, Hwang Jun-Eul, Bae Woo-Kyun, Chung Ik-Joo, Kim Hee-Nam, Shin Min-Ho, Cho Sang-H |
| XRCC1 Gene Polymorphisms and miR-21 Expression in Patients with Colorectal Carcinoma. The Eurasian journal of medicine 2017 Jun 49 (2): 132-136. Fouad Hanan, Sabry Dina, Morsi Heba, Shehab Hany, Abuzaid Naglaa |
| Colorectal Cancer Carcinogenesis: a Multivariate Genetic Model in a Cohort of Romanian Population. Clinical laboratory 2017 Apr 63 (4): 647-658. Procopciuc Lucia M, Osian Gelu, Iancu Mihae |
| X-ray cross-complementing groups 1 rs1799782 C>T polymorphisms and colorectal cancer susceptibility: A meta-analysis based on Chinese Han population. Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C264-C267. Wang Liming, Qian Junfeng, Ying Chunxiao, Zhuang Yongwei, Shang Xingjie, Xu Fa |
| Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients. Cancer genetics 2017 Dec 218-219 51-57. Zhang Liping, Zhao Jiangman, Yu Bin, Song Xinjiang, Sun Guogang, Han Lijiang, Wang Lu, Dong S |
| Lack of correlation between X-ray repair cross-complementing group 1 gene polymorphisms and the susceptibility to colorectal cancer in a Malaysian cohort. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2017 Jan . Lau Tze-Pheng, Lian Lay-Hoong, Cheah Phaik-Leng, Looi Lai-Meng, Roslani April C, Goh Khean-Lee, Lee Ping-Chin, Chua Kek-He |
| Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy. European journal of cancer (Oxford, England : 1990) 2018 8 102 31-39. Madi Ayman, Fisher David, Maughan Timothy S, Colley James P, Meade Angela M, Maynard Julie, Humphreys Vikki, Wasan Harpreet, Adams Richard A, Idziaszczyk Shelley, Harris Rebecca, Kaplan Richard S, Cheadle Jeremy |
| The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis. Journal of Cancer 2018 9 (8): 1506-1517. Du Le, Lei Lei, Zhao Xiaojuan, He Hongjuan, Chen Erfei, Dong Jing, Zeng Yuan, Yang J |
| Analysis of 12 variants in the development of gastric and colorectal cancers. World journal of gastroenterology 2017 Dec 23 (48): 8533-8543. Cavalcante Giovanna C, Amador Marcos At, Ribeiro Dos Santos André M, Carvalho Darlen C, Andrade Roberta B, Pereira Esdras Eb, Fernandes Marianne R, Costa Danielle F, Santos Ney Pc, Assumpção Paulo P, Ribeiro Dos Santos Ândrea, Santos Sidn |
| Influence of Two DNA Repair Pathway Polymorphisms in Colorectal Cancer Risk in Southwest Iran. Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 1919-1924. Hosseini Seyed Mohammad, Mohammadiasl Javad, Talaiezadeh Abdulhasan, Alidadi Rahim, Bijanzadeh Mah |
| Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics? Journal of chemotherapy (Florence, Italy) 2020 May 1-13. Duran Goretti, Cruz Raquel, Simoes Ana Rita, Barros Francisco, Giráldez José María, Bernárdez Beatriz, Anido Urbano, Candamio Sonia, López-López Rafael, Carracedo Ángel, Lamas María Jes |
| Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. BMC cancer 2020 May 20 (1): 409. Salimzadeh Hamideh, Lindskog Elinor Bexe, Gustavsson Bengt, Wettergren Yvonne, Ljungman Dav |
| The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population. Medical journal of the Islamic Republic of Iran 2020 34 75. Mehrzad Jamshid, Dayyani Mahdieh, Erfanian-Khorasani Mohammadre |
| [The influence of XRCC1 gene polymorphism on the prognosis and safety of stage ? patients with colorectal cancer who received oxaliplatin based adjuvant chemotherapy]. Zhonghua yi xue za zhi 2021 Mar 101 (11): 759-765. Li R X, Shang J H, Sun J |
| Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. Journal of inflammation research 2021 11 14 5403-5417. Zhang Yu, Zhang Xin, Jin Zhuoyi, Chen Huiyan, Zhang Chenjing, Wang Wangyue, Jing Jiyong, Pan Wenshe |
| Association of base excision repair pathway genes OGG1, XRCC1 and MUTYH polymorphisms and the level of 8-oxo-guanine with increased risk of colorectal cancer occurrence. International journal of occupational medicine and environmental health 2022 Jun . Kabzi?ski Jacek, Majsterek Ireneu |
| The role of heavy metals in the development of colorectal cancer. BMC cancer 2023 7 23 (1): 616. Yongsheng Li, Jingwei Lou, Shaozhong Hong, Dengfeng Hou, Yandong Lv, Zhiqiang Guo, Kai Wang, Yue Xu, Yufeng Zhai, Hongzhou L |
| Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer. International journal of molecular sciences 2024 1 25 (1): . Yasmin Cura, Almudena Sánchez-Martín, Noelia Márquez-Pete, Encarnación González-Flores, Fernando Martínez-Martínez, Cristina Pérez-Ramírez, Alberto Jiménez-Moral |
- Page last reviewed:Feb 1, 2024
- Content source: